Actively Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Led by Dogwood Therapeutics Inc. · Updated on 2026-01-12
200
Participants Needed
24
Research Sites
75 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomized study to determine safety and efficacy of single subcutaneous (SC) administration of HAL treatment in patients with CINP.
CONDITIONS
Official Title
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients aged ≥18 years.
- Neuropathic pain has been present and is attributed to platinum and/or taxane chemotherapy.
- Patient has received a cancer chemotherapy regimen that included taxanes and/or platinum and has no active or discernible disease progression.
You will not qualify if you...
- Current neuropathic pain with symptoms similar to CINP but attributed to causes other than platinum or taxane chemotherapy.
- Patients who have received HAL at any time prior to screening.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 24 locations
1
Central Recruiting Site
Sheffield, Alabama, United States, 35660
Actively Recruiting
2
Central Recruiting Site
Glendale, Arizona, United States, 85308
Actively Recruiting
3
Central Recruiting Site
Fair Oaks, California, United States, 95628
Actively Recruiting
4
Central Recruiting Site
Fountain Valley, California, United States, 92708
Actively Recruiting
5
Central Recruiting Site
Los Angeles, California, United States, 91307
Actively Recruiting
6
Central Recruiting Site
Santa Rosa, California, United States, 95403
Actively Recruiting
7
Central Recruiting Site
Wheat Ridge, Colorado, United States, 80033
Actively Recruiting
8
Central Recruiting Site
Jacksonville, Florida, United States, 32205
Actively Recruiting
9
Central Recruiting Site
Jacksonville, Florida, United States, 32256
Actively Recruiting
10
Central Recruiting Site
Lakeland, Florida, United States, 33812
Actively Recruiting
11
Central Recruiting Site
Orlando, Florida, United States, 32832
Actively Recruiting
12
Central Recruiting Site
Port Charlotte, Florida, United States, 33952
Actively Recruiting
13
Central Recruiting Site
Tampa, Florida, United States, 33613
Actively Recruiting
14
Central Recruiting Site
Atlanta, Georgia, United States, 30331
Actively Recruiting
15
Central Recruiting Site
Gurnee, Illinois, United States, 60031
Actively Recruiting
16
Central Recruiting Site
Farmington, Michigan, United States, 48334
Actively Recruiting
17
Central Recruiting Site
Fenton, Missouri, United States, 63026
Actively Recruiting
18
Central Recruiting Site
Kansas City, Missouri, United States, 64111
Actively Recruiting
19
Central Recruiting Site
Las Vegas, Nevada, United States, 89109
Actively Recruiting
20
Central Recruiting Site
Garden City, New York, United States, 11530
Actively Recruiting
21
Central Recruiting Site
Williamsville, New York, United States, 14221
Actively Recruiting
22
Central Recruiting Site
Winston-Salem, North Carolina, United States, 27103
Actively Recruiting
23
Central Recruiting Site
Salt Lake City, Utah, United States, 84107
Actively Recruiting
24
Central Recruiting Site
Madison, Wisconsin, United States, 53715
Actively Recruiting
Research Team
D
Dogwood Therapeutics
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here